B. Riley Forecasts Higher Earnings for ArriVent BioPharma
ArriVent BioPharma, Inc. (NASDAQ:AVBP – Free Report) – Equities research analysts at B. Riley lifted their Q2 2025 earnings per share estimates for shares of ArriVent BioPharma in a report issued on Monday, May 12th. B. Riley analyst K. Patel now forecasts that the company will post earnings of ($0.52) per share for the quarter, […]
